Exercise of over-allotment option, stabilisation notice and end of the stabilisation period
NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, JAPAN OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, DISTRIBUTION OR PUBLICATION WOULD BE UNLAWFUL OR REQUIRE REGISTRATION OR ANY OTHER MEASURE. Erik Penser Bank AB (publ) (”Erik Penser Bank”) notifies that stabilisation measures have been undertaken in Ascelia Pharma AB’s (publ) (”Ascelia Pharma” or the “Company”) shares on Nasdaq Stockholm, that Erik Penser Bank exercises the over-allotment option regarding 882,017 shares in Ascelia Pharma and that the stabilization
